Erin VanDyke: NBCA Centers of Excellence Aim to Improve Blood Clot Care
Erin VanDyke, Vice President of National Blood Clot Alliance Centers of Excellence, shared a post on LinkedIn:
“Two sides of the same bedrail
On one side:
- From an international NBCA survey of 1,050 blood clot patients (May–June 2023):
- 65% said the diagnosis discussion lasted less than 10 minutes
- Only 55% felt their diagnosis explanation was satisfactory
- Just 16% received printed or electronic educational materials at diagnosis
- 48% recalled receiving detailed information about anticoagulation risks and benefits
- 35% weren’t diagnosed correctly on their first visit (50% required 3+ visits)
- 32% of inpatients returned because symptoms persisted
On the other side:
- Clinical teams are struggling too:
- Over 50% of physicians report burnout, with highest rates among emergency physicians (65%), internists (60%), and pediatricians (59%)
- Nearly 80% of physicians described their level of burnout as moderate to severe, and the majority (65%) said it has harmed their relationships.
- 41.4% of PAs had burnout symptoms in a national survey, compared with other U.S. workers.
- Burnout is strongly linked to intention to leave medicine, threatening continuity of care
- Nurses report that burnout directly impacts patient safety, satisfaction, and quality of care, while also driving workforce turnover
Both patients and clinical teams are navigating a system that leaves them frustrated, exhausted, and often underserved.
That’s where National Blood Clot Alliance Center of Excellence (COE) program comes in. These centers are challenged with the unique task of bringing patients, clinicians, and the community together—standardizing pathways, strengthening communication, and improving education—so that care works better for everyone.
When we step across the bedrail—patients seeing the challenges clinical teams face, clinicians truly hearing the patient’s experience—we can begin to design care that improves outcomes and restores trust.”
Find more posts on Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch